Your search returned 719 results.

Results
	401.	Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation. [electronic resource] by Zhang, Shirong Zheng, Xiaoliang Huang, Haixiu Wu, Kan Wang, Bing Chen, Xufeng Ma, Shenglin Producer: 20160302 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	402.	Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer. [electronic resource] by Ding, Pei Ni Lord, Sarah J Gebski, Val Links, Matthew Bray, Victoria Gralla, Richard J Yang, James Chih-Hsin Lee, Chee Khoon Producer: 20171116 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	403.	[Evidence on afatinib in patients progressing on a first-line treatment]. [electronic resource] by Artal Cortés, Ángel Gimeno Pelegrín, Joaquín Alejandro, María Álvarez Producer: 20171109 In: Medicina clinica vol. 146 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	404.	Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2. [electronic resource] by Bahleda, Rastislav Varga, Andrea Bergé, Yann Soria, Jean-Charles Schnell, David Tschoepe, Inga Uttenreuther-Fischer, Martina Delord, Jean-Pierre Producer: 20190405 In: British journal of cancer vol. 118 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	405.	Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib. [electronic resource] by Niebecker, Ronald Maas, Hugo Staab, Alexander Freiwald, Matthias Karlsson, Mats O Producer: 20200727 In: CPT: pharmacometrics & systems pharmacology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	406.	Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses. [electronic resource] by Sundaresan, Tilak K Sequist, Lecia V Heymach, John V Riely, Gregory J Jänne, Pasi A Koch, Walter H Sullivan, James P Fox, Douglas B Maher, Robert Muzikansky, Alona Webb, Andrew Tran, Hai T Giri, Uma Fleisher, Martin Yu, Helena A Wei, Wen Johnson, Bruce E Barber, Thomas A Walsh, John R Engelman, Jeffrey A Stott, Shannon L Kapur, Ravi Maheswaran, Shyamala Toner, Mehmet Haber, Daniel A Producer: 20161213 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	407.	Update on afatinib-based combination regimens for the treatment of EGFR mutation-positive non-small-cell lung cancer. [electronic resource] by Bennouna, Jaafar Producer: 20180814 In: Future oncology (London, England) vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	408.	Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases. [electronic resource] by Cho, Yung-Tsu Chen, Kai-Lung Sheen, Yi-Shuan Yang, Che-Wen Liau, Jau-Yu Cheng, Yu-Pin Chu, Chia-Yu Producer: 20171012 In: JAMA dermatology vol. 153 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	409.	Afatinib is active in osteosarcoma in osteosarcoma cell lines. [electronic resource] by Cruz-Ramos, Marlid Zamudio-Cuevas, Yessica Medina-Luna, Daniel Martínez-Flores, Karina Martínez-Nava, Gabriela Fernández-Torres, Javier López-Reyes, Alberto Solca, Flavio Producer: 20200615 In: Journal of cancer research and clinical oncology vol. 146 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	410.	Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer: a meta-analysis of 24 phase III clinical trials. [electronic resource] by Qi, Wei-Xiang Sun, Yuan-Jue Shen, Zan Yao, Yang Producer: 20150915 In: Journal of chemotherapy (Florence, Italy) vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	411.	A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors. [electronic resource] by Chu, Quincy S Sangha, Randeep Hotte, Sebastien J Sergenson, Gwen Schnell, David Chand, Vikram K Hirte, Hal W Producer: 20150713 In: Investigational new drugs vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	412.	Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. [electronic resource] by Heigener, David F Schumann, Christian Sebastian, Martin Sadjadian, Parvis Stehle, Ingo Märten, Angela Lüers, Anne Griesinger, Frank Scheffler, Matthias Producer: 20160707 In: The oncologist vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	413.	EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors. [electronic resource] by Ercan, Dalia Choi, Hwan Geun Yun, Cai-Hong Capelletti, Marzia Xie, Ting Eck, Michael J Gray, Nathanael S Jänne, Pasi A Producer: 20160607 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	414.	Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines. [electronic resource] by De Pauw, Ines Lardon, Filip Van den Bossche, Jolien Baysal, Hasan Fransen, Erik Deschoolmeester, Vanessa Pauwels, Patrick Peeters, Marc Vermorken, Jan Baptist Wouters, An Producer: 20190517 In: Molecular oncology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	415.	Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines. [electronic resource] by Collins, Denis M Gately, Kathy Hughes, Clare Edwards, Connla Davies, Anthony Madden, Stephen F O'Byrne, Kenneth J O'Donovan, Norma Crown, John Producer: 20171003 In: Cellular immunology vol. 319 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	416.	Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy. [electronic resource] by Meriggi, Fausto Codignola, Claudio Beretta, Giordano D Ceresoli, Giovanni L Caprioli, Alberto Scartozzi, Mario Fraccon, Anna P Prochilo, Tiziana Ogliosi, Chiara Zaniboni, Alberto Producer: 20171016 In: Tumori vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	417.	Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. [electronic resource] by Dunn, Lara A Fury, Matthew G Sherman, Eric J Ho, Alan A Katabi, Nora Haque, Sofia S Pfister, David G Producer: 20190520 In: Head & neck vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	418.	Afatinib treatment for her-2 amplified metastatic colorectal cancer based on patient-derived xenograft models and next generation sequencing. [electronic resource] by Yang, Mengyuan Fang, Xuefeng Li, Jun Xu, Dong Xiao, Qian Yu, Shaojun Hu, Hanguang Weng, Shanshan Ding, Kefeng Yuan, Ying Producer: 20200701 In: Cancer biology & therapy vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	419.	Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors. [electronic resource] by Chang, Lih-Chyun Lim, Chor-Kuan Chang, Lih-Yu Chen, Kuan-Yu Shih, Jin-Yuan Yu, Chong-Jen Producer: 20200608 In: European journal of cancer (Oxford, England : 1990) vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	420.	Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET. [electronic resource] by Scheffler, Matthias Kobe, Carsten Zander, Thomas Nogova, Lucia Kahraman, Deniz Thomas, Roman Neumaier, Bernd Dietlein, Markus Wolf, Jürgen Producer: 20121221 In: Lung cancer (Amsterdam, Netherlands) vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.